Skip to content

Traumafix System, Model TFX.00.00.X

by Sintea Biotech, Inc.

510(k) K022065

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK022065 Date6 Aug 2002ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Sintea Biotech Traumafix System, Model TFX.00.00.X
510(k) Number
FDA Product Code
JEC
Device Class
Class II
Regulation
21 CFR Part 888.3040
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Traumafix System, Model TFX.00.00.X, is an external circular traction device designed for orthopedic applications. It provides mechanical fixation to bone through metallic components, enabling stabilization for fracture management, limb lengthening, and reconstruction procedures. This system is classified as an invasive orthopedic device under FDA regulations.

The device is intended for use in clinical or hospital settings by orthopedic surgeons. It is supplied as a reusable system with metallic components and has received FDA 510(k) clearance under the Traditional pathway, classified as a Class II device. The system includes Schanz screw components and adheres to regulatory standards outlined in regulation number 888.3040. No specific sterility or MRI safety information is provided in the available data.

Other devices from Sintea Biotech, Inc.

See all devices from Sintea Biotech, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is the Traumafix System reusable or single-use, and what does this mean for my hospital’s workflow?

    The Traumafix System is designed as a reusable device, meaning its metallic components are intended for repeated use across multiple patients after proper cleaning, sterilization, and maintenance. This makes it suitable for clinical or hospital settings where infection control and cost efficiency are priorities. However, hospitals must follow strict reprocessing protocols to ensure sterility and functionality between uses, as no specific sterility guarantees are provided in the available data.

  • What types of orthopedic procedures is the Traumafix System primarily used for, and how does it stabilize fractures?

    The Traumafix System is specifically designed for external circular traction, providing mechanical fixation to bone through Schanz screws and metallic components. It is used for fracture management, limb lengthening, and reconstruction procedures by applying controlled traction to stabilize bone alignment. The system’s circular design allows for multi-directional stabilization, which is critical for complex orthopedic cases requiring precise alignment and gradual correction.

  • Are there different sizes or models available for the Traumafix System, and how do I determine the right fit for a patient?

    The Traumafix System is available in multiple configurations under the TFX.00.00.X model series, though specific size variations (e.g., screw diameters, ring diameters, or frame sizes) are not detailed in the provided data. Selection typically depends on the patient’s anatomy, the type of procedure, and the surgeon’s assessment of the required traction force. Clinicians should consult the manufacturer’s technical documentation or a Sintea Biotech representative to match the appropriate components to the patient’s needs.

  • How was the Traumafix System’s safety and equivalence to prior devices evaluated by the FDA, and what does the ‘Traditional 510(k)’ pathway mean?

    The Traumafix System received FDA 510(k) clearance under the Traditional pathway, meaning its safety and performance were compared to legally marketed predicate devices (those already cleared for similar uses) to demonstrate substantial equivalence. The FDA classified it as a Class II device under regulation 888.3040, indicating it poses moderate risk and requires special controls beyond general controls. The clearance was granted in 2002, and the system is intended for use by orthopedic surgeons in clinical settings.

  • Does the Traumafix System have any limitations regarding MRI compatibility or special handling requirements?

    The available data does not specify MRI safety information for the Traumafix System, meaning its compatibility with MRI machines (e.g., whether metallic components could cause artifacts or pose risks) is not addressed. Clinicians should verify compatibility with their MRI equipment and consult the manufacturer before using the system in an MRI environment. Additionally, since it is a reusable device, proper cleaning and sterilization protocols must be followed to prevent cross-contamination.